Prescribing practices of child psychiatrists in the UK

Child Psychology and Psychiatry Review

Volumn 6, Issue 4, 2001, Pages 166-171

  McNicholas, Fiona ^a,b  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b Lucena Clinic   (Ireland)

Author keywords

Child psychiatrists; Prescribing practices; Psychopharmacology

Indexed keywords

EID: 0041584999     PISSN: 13606417     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1360641701002726     Document Type: Article

References (30)

1. Adams, S. (1991). Prescribing of psychotropic drugs to children and adolescents. British Medical Journal, 302, 217.
2. Bramble, D. (1997). Psycho-stimulants and British child psychiatrists. Child Psychology and Psychiatry Review, 2, 159-162.
3. Boulos, C., Kutcher, S., Gardner, D., & Young, E. (1992). An open naturalistic trial of fluoxetine in adolescents and young adults with treatment resistant major depression. Journal of Child and Adolescent Psychopharmacology, 2, 103-111.
4. Chugani, H. T., Phelps, M. E., & Mazziotta, J. (1997). Posutron emission tomography study of human brain functional development. Annals of Neurology, 22, 487-497.
5. Emslie, G. J., Rush, A. J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., & Rintelmann, J. (1997). A double blind randomised, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031-1037.
6. Ghaziuddin, N., Naylor, M. W., & King, C. A. (1995). Fluoxetine in tricyclic refractory depression in adolescents. Depression, 2, 287-291.
7. Goldman-Rakic, C. P., & Brown, R. M. (1982). Post-natal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Developmental Brain Research, 4, 339-349.
8. Hazell, P., O'Connell, D., Heathcote, D., Robertson, J., & Henry, D. (1995). Efficacy of tri-cyclic drugs in treating child and adolescent depression: A meta analysis. British Medical Journal, 310, 897-901.
9. Horrigan, J. P., Barnhill, L. J., & Courvoisie, H. F. (1997). Olanzapine in PDD. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1166-1167.
10. Huttenlocher, P. R. (1990). Morphometric study of human cerebral development. Neuropsychologia, 28, 517-527.
11. James, A. C. (1996). A survey of the prescribing practices of child and adolescent psychiatrists. Child Psychology and Psychiatry Review, 1, 94-97.
12. Jensen, P. S. (1998). Ethical and pragmatic issues in the use of psychotropic agents in young children. Canadian Journal of Psychiatry, 43, 585-588.
13. Joshi, P., Hamel, L., Joshi, A. R. T., & Capozzoli, J. A. (1998). Use of droperidol in hospitalised children. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 228-230.
14. Kaplan, C. A., & Hussain, S. (1995). Use of drugs in child and adolescent psychiatry. Review Article. British Journal of Psychiatry, 166, 291-298.
15. Kaplan, S. L., Simms, R. M., & Busner, J. (1994). Prescribing practices of outpatient child psychiatrists. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 35-44.
16. Kewley, G. D. (1999). Risperidone in comorbid ADHD and ODC/CD. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1327-1328.
17. Mazer, C., Muneyyirci, J., Taheny, K., Raio, N., Borella, A., & Whitaker-Azmitia, P. (1997). Serotonin depletion during synaptogeniesis leads to decreased synaptic density and learning deficits in the adult rat: A possible model of neurodevelopmental disorders with cognitive deficits. Brain Research, 760, 68-73.
18. Minde, K. (1998). The use of psychotropic medication in preschoolers: Some recent developments. Canadian Journal of Psychiatry, 43, 571-575.
19. Pincus, H. A., Tanielian, T. L., Marcus, S. C., Olfson, M., Zarin, D. A., Thompson, J., & Zito, J. M. (1998). Prescribing trends in psychotropic medications, primary care, psychiatry and other medical specialties. Journal of the American Medical Association, 279, 526-531.
20. Rappley, M. D., Mullan, P. B., Wang, J., & Alvarez, F. J., Eneli, I. U., & Gardiner, J. C. (1999). Diagnosis of attention deficit/hyperactivity disorder and use of psychotropic medication in very young children. Archives of Pediatrics and Adolescent Medicine, 153, 1039-1045.
21. Rosengarten, H., & Friedhoff, A. J. (1979). Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Science, 203, 1133-1135.
22. Safer, D. J., & Krager, J. M. (1988). A survey of medication treatment for hyperactive/inattentive students. Journal of the American Medical Association, 260, 2256-2258.
23. Schreier, H. A. (1998). Risperidone for young children with mood disorders and aggressive behaviour. Journal of Child and Adolescent Psychopharmacology, 8,49-59.
24. Seeman, P., Bzowej, N. H., Guan, H. C., Bergeron, C., Becker, L. E., & Reynolds, G. P. (1987). Human brain dopamine receptors in children and aging adults. Synapse, 1, 399-404.
25. Slaveska, K., Hollis, C. & Bramble, D. (1998). Use of antipsychotics by child and adolescent psychiatrists. Psychiatric Bulletin, 22, 685-687.
26. Treatment for Adolescents with Depression Study (TADS) RFP-NIH-NIMH-98-DS-0008 Principal Investigator: John March, Duke University, NC.
27. Vitiello, B. (1998). Pediatric psychopharmacology and the interaction between drugs and the developing brain. Canadian Journal of Psychiatry, 43, 582-584.
28. Waslick, B. D., Walsh, B. T., Greenhill, L. L., Eilenberg, M., Capasso, L., & Lieber, D. (1999). Open trial of fluoxetine in children and adolescents with dysthymic disorder or double depression. Journal of Affective Disorders, 56, 227-236.
29. Weizman, A., Weitz, R., Szekely, G. A., Tyano, S., & Belmaker, R. H. (1984). Combination of neuroleptic and stimulant treatment in attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 23, 295-298.
30. Zito, J. M., Safer, D. J., dos Reis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000). Trends in prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283, 1025-1030.